Medical Condition News

RSS

Study shows lack of protease-activated receptors may cause neural tube defects

New research, published by Cell Press in the January 19th issue of the journal Developmental Cell, provides intriguing insight into how the nervous system forms during very early embryonic development.

20 Jan 2010

Carlos Slim Health Institute launches major research project in genomic medicine

Mexican business leader Carlos Slim Hel- today announced the launch of a major research project in genomic medicine that will help accelerate progress in public health in Mexico and around the world.

20 Jan 2010

New heating therapy reduces mastectomies, kills large tumors

A new treatment developed and tested by University of Oklahoma researchers not only killed large breast cancer tumors, but reduced the need for mastectomies by almost 90 percent. The latest results appear in an upcoming issue of the Annals of Surgical Oncology.

20 Jan 2010

HSF1A stimulates more protein chaperones and reduces protein misfolding

Scientists at Duke University Medical Center have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases, including Huntington's disease, Alzheimer's disease and Parkinson's disease.

20 Jan 2010

Researchers show how gliomas can evade drugs aimed at blocking EGFR

Researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine and Moores UCSD Cancer Center have shown one way in which gliomas, a deadly type of brain tumor, can evade drugs aimed at blocking a key cell signaling protein, epidermal growth factor receptor (EGFR),that is crucial for tumor growth.

20 Jan 2010

Zeshaan A. Rasheed receives the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Zeshaan A. Rasheed, M.D., Ph.D., the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant.

20 Jan 2010

Cardiac RSR test can quickly and accurately detect the presence of S-CAD

Testing a patient's cardiac respiratory stress response (RSR) can quickly and accurately detect the presence of significant coronary artery disease (S-CAD), according to new research published in the current issue of Cardiovascular Revascularization Medicine.

20 Jan 2010

Navigating Cancer announces the launch of new, free website for cancer patients

Navigating Cancer announced today the public beta launch of its new, free website specifically for cancer patients, www.navigatingcancer.com. Navigating Cancer provides essential cancer-related information from authoritative sources to help patients learn about their options once diagnosed, and tools for patients to partner with their physicians, allowing them to be more in control of their cancer treatment and care.

20 Jan 2010

Ericson Manufacturing supports breast cancer research and community outreach projects

In 2010 Ericson Manufacturing Company will make significant strides in the support of national breast cancer awareness through a new partnership with Susan G. Komen for the Cure®, the world’s largest breast cancer advocacy organization.

20 Jan 2010

Epidemiologic characteristics of young age GC patients vary by age and gender

Two percent to fifteen percent of patients with gastric cancer (GC) are younger than 45 years of age and there has been an increase in the relative proportion of young age GC compared with older age GC, especially in young females.

20 Jan 2010

Fc engineering enhances antibody half-life

A Nature Biotechnology article published online January 17 reveals that Xencor Inc.’s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, “Enhanced antibody half-life improves in vivo activity” demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.

20 Jan 2010

GEH, Exelon Generation agree to a landmark deal to deploy GEH’s isotope generation technology

Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to deploy GEH’s isotope generation technology.

20 Jan 2010

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Signaling its continued commitment to addressing the anatomy of the entire peripheral vasculature and combating disease with targeted diagnostic and interventional devices, Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy.

20 Jan 2010

Gene variant predisposes humans to develop acute myeloid leukemia, says study

A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.

20 Jan 2010

Fast Forward, JDRF announce collaborative partnership with Axxam SpA

Fast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world today announced a collaborative partnership with Axxam SpA -- a leading company in conducting early-stage discovery research programs for the life science industry -- to develop new treatments for two autoimmune diseases, multiple sclerosis (MS) and type 1 diabetes (T1D).

20 Jan 2010

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington’s disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

20 Jan 2010

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.

20 Jan 2010

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps.

From BD (Becton, Dickinson and Company) 20 Jan 2010

European Breast Cancer Conference in Barcelona, Spain

The 7th European Breast Cancer Conference (EBCC-7) will be held in Barcelona, Spain (Centre Convencions Internacional (CCIB - FORUM), Rambla Prim 1-17, ES-08019) from Wednesday 24 - Saturday 27 March 2010.

20 Jan 2010

LEO Pharma launches psoriasis franchise in the U.S.

Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company’s network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.

20 Jan 2010

Medical Condition News

Study shows lack of protease-activated receptors may cause neural tube defects

Carlos Slim Health Institute launches major research project in genomic medicine

New heating therapy reduces mastectomies, kills large tumors

HSF1A stimulates more protein chaperones and reduces protein misfolding

Researchers show how gliomas can evade drugs aimed at blocking EGFR

Zeshaan A. Rasheed receives the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

Cardiac RSR test can quickly and accurately detect the presence of S-CAD

Navigating Cancer announces the launch of new, free website for cancer patients

Ericson Manufacturing supports breast cancer research and community outreach projects

Epidemiologic characteristics of young age GC patients vary by age and gender

Fc engineering enhances antibody half-life

GEH, Exelon Generation agree to a landmark deal to deploy GEH’s isotope generation technology

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Gene variant predisposes humans to develop acute myeloid leukemia, says study

Fast Forward, JDRF announce collaborative partnership with Axxam SpA

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

European Breast Cancer Conference in Barcelona, Spain

LEO Pharma launches psoriasis franchise in the U.S.

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News